Research on stem cell therapy has shown promise as a therapy for multiple sclerosis. Which type of stem cells do you think shows the most promise for patients with advanced multiple sclerosis?
Recent research has shown that short-course antibiotic therapy may be as effective as longer-course therapy for patients with community-acquired pneumonia. Do you think a shorter course of antibiotic...
New research indicates that treatment with fecal microbiota may help prevent additional infections in patients with Clostridioides difficile infection. Take our poll to let us know your view on this...
Physicians are increasingly using technology to maintain contact with their patients during the COVID-19 pandemic, from telemedicine to texting. Do you personally use social media to communicate with...
Immunoautonomics is a growing field and is leading to new and more-targeted immunotherapies. Do you think these advancements will predict treatment outcomes for patients with rheumatoid arthritis?
To prevent the spread of COVID-19, clinicians have begun to use video and audio technology to connect with patients. Are you participating in telehealth with your patients during this time? Let us know by...
It is sometimes challenging to capture multiple sclerosis disease activity and, therefore, to track the efficacy of interventions. Do you think current measures are relevant for assessing intervention...
Recent data indicate long-term use of benralizumab is safe and effective for younger patients. Would you prescribe benralizumab to your adolescent patients with uncontrolled asthma?
In a recent study, researchers investigated the impact of soft drink consumption on morbidity and mortality, as well as the differing effects of sugar-sweetened and artificially sweetened soft drinks. When...
Do you think the new classification criteria for IgG4-RD will increase the inclusion of people with IgG4-RD in clinical trials and observational studies? Let us know by taking the poll.
